CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Ryszard Slomski

OPENALEX: A5039540008↗ORCID: 0000-0001-5601-7002↗

Affiliations

Organizations

Institute of Human Geneticsauthorship · PL Institute of Natural Fibres and Medicinal Plantsauthorship · PL Polish Academy of Sciencesauthorship · PL University of Life Sciences in Poznańauthorship · PL

Public evidence

7 connected articles

<i>Cannabis sativa</i> L. Extract Increases COX-1, COX-2 and TNF-α in the Hippocampus of Rats with Neuropathic Pain.2025 · Europe PMC <i>Cannabis sativa</i> L. Extract Alleviates Neuropathic Pain and Modulates CB1 and CB2 Receptor Expression in Rat.2024 · Europe PMC THC-Reduced <i>Cannabis sativa</i> L.-How Does the Solvent Determine the Bioavailability of Cannabinoids Given Orally?2023 · Europe PMC What Role Does the Endocannabinoid System Play in the Pathogenesis of Obesity?2021 · Europe PMC Allosteric Modulation of Cannabinoid Receptor 1-Current Challenges and Future Opportunities.2019 · Europe PMC The current state and future perspectives of cannabinoids in cancer biology.2018 · Europe PMC Pharmacogenetics of Cannabinoids.2018 · Europe PMC

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.

Ryszard Slomski - Medical Cannabis Research Engine